- Business Wire•15 hours ago
CEL-SCI Corporation announced today that it has priced its public offering of common stock and warrants.
- Business Wire•yesterday
CEL-SCI Corporation announced today that it intends to offer and sell, subject to market and other conditions shares of its common stock and warrants to purchase common stock.
- Business Wire•12 days ago
CEL-SCI Corporation announced today that it has submitted its response to the U.S. Food and Drug Administration regarding the previously announced partial clinical hold of CEL-SCI’s Phase 3 clinical trial of its investigational drug Multikine* in patients with squamous cell carcinoma of the head and neck.
CVM : Summary for Cel-Sci Corporation Common Stoc - Yahoo Finance
CEL-SCI Corporation (CVM)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Bid||0.11 x 100|
|Ask||0.11 x 300|
|Day's Range||0.10 - 0.12|
|52 Week Range||0.10 - 0.66|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.63|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|